Literature DB >> 20355187

Counterfeiting in performance- and image-enhancing drugs.

Michael R Graham1, Paul Ryan, Julien S Baker, Bruce Davies, Non-Eleri Thomas, Stephen-Mark Cooper, Peter Evans, Sue Easmon, Christopher J Walker, David Cowan, Andrew T Kicman.   

Abstract

The current drastic escalation in obesity may be contributing to the exponential rise in drugs used for image enhancement. Drugs such as anabolic-androgenic steroids (AAS) are perceived as a viable method of achieving a perfect physique. They are also the most widely abused drugs in sport. The Internet has encouraged the abuse of expensive drugs, particularly human growth hormone (hGH), resulting in increased importation for personal use. The substantial increase in this market has opened up avenues for counterfeiting, estimated as a multi-million pound business. The acute adverse effects from contaminated vials may result in a variety of pathologies including communicable diseases. In 2007, in the UK, a series of intramuscular abscesses, requiring surgical treatment, led us to study samples obtained from the underground market. The analysis of 38 parenteral samples and 19 oral samples of tablets was performed by a World Anti-Doping Agency (WADA) accredited laboratory, in an attempt to establish the extent of available counterfeit products. Fifty-three per cent (20) of the injectable AAS esters and 21% (4) of the oral tablets were counterfeit. Culture and sensitivity revealed the presence of skin commensal organisms, which may have contributed to the development of the abscesses. Users of AAS and hGH for sport, including bodybuilding, are currently risking their health because of counterfeit and poorly controlled products. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20355187     DOI: 10.1002/dta.30

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  12 in total

Review 1.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

2.  Availability and quality of illegitimate somatropin products obtained from the Internet.

Authors:  Róbert György Vida; András Fittler; Ivett Mikulka; Eszter Ábrahám; Viktor Sándor; Ferenc Kilár; Lajos Botz
Journal:  Int J Clin Pharm       Date:  2016-11-25

Review 3.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

4.  Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature.

Authors:  Raphael Magnolini; Luis Falcato; Alessio Cremonesi; Dominique Schori; Philip Bruggmann
Journal:  BMC Public Health       Date:  2022-07-17       Impact factor: 4.135

5.  Self-Perceived Weight and Anabolic Steroid Misuse Among US Adolescent Boys.

Authors:  Jonathan D Jampel; Stuart B Murray; Scott Griffiths; Aaron J Blashill
Journal:  J Adolesc Health       Date:  2015-11-17       Impact factor: 5.012

6.  Estimating the Effect of Health Insurance on Personal Prescription Drug Importation.

Authors:  Andrew R Zullo; Chanelle J Howe; Omar Galárraga
Journal:  Med Care Res Rev       Date:  2016-08-03       Impact factor: 3.929

Review 7.  Synthetic androgens as designer supplements.

Authors:  Jan Felix Joseph; Maria Kristina Parr
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

8.  Simple Synthesis of 17-β-O-hemisuccinate of Stanozolol for Immunoanalytical Methods.

Authors:  Silvana Casati; Roberta Ottria; Pierangela Ciuffreda
Journal:  Molecules       Date:  2020-04-26       Impact factor: 4.411

9.  The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study.

Authors:  Ornella Corazza; Pierluigi Simonato; Zsolt Demetrovics; Roisin Mooney; Katinka van de Ven; Andres Roman-Urrestarazu; Lili Rácmolnár; Ilaria De Luca; Eduardo Cinosi; Rita Santacroce; Massimo Marini; David Wellsted; Keith Sullivan; Giuseppe Bersani; Giovanni Martinotti
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.